HeartBeam Launches Pilot Study for On-Demand 12-Lead ECG Patch
HeartBeam launches pilot study for its on-demand 12-lead ECG patch to detect coronary artery disease and ischemia. The technology could disrupt the $2 billion cardiac monitoring market.
This news matters because coronary artery disease remains a leading cause of death globally, often undetected until a major event. The HeartBeam patch could enable earlier, more accessible detection of ischemia from home, potentially saving lives and reducing healthcare costs. If proven effective, it may disrupt the $2 billion cardiac monitoring market and empower patients with on-demand, clinical-grade insights.
